Mr. Rowland has been a member of the board since March. He will replace the company’s founder and current CEO Elazar Sonnenschein, MD, upon shareholder approval.
Mr. Rowland served for 17 years as a manager for Boston Scientific and has 24 years of experience in the life sciences market.
Medigus develops minimally invasive endoscopic techniques for gastroesophageal reflux disease treatment.
More Articles on Gastroenterology:
GI, Endoscopy Video Journal Released by Elsevier
Study: Probiotics May Not Relieve Antibiotic-Associated Diarrhea in Elderly
European Researchers Zero In On Possible Bowel Disease Cause
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
